Role of immunomodulators in treatment of chronic obstructive pulmonary disease

Abstract

Statistics from around the world show a steady increase in morbidity and mortality from chronic obstructive pulmonary disease. Currently, quite a promising direction is to assess the relationship of immunosuppression of the respiratory system and inflammatory response. Imbalance in the immune system often leads to recurrent, sluggish exacerbation of the disease, deterioration of prognosis and quality of life. The duration of the disease is directly related to more severe violations of cellular and humoral immunity. From this perspective, it is promising to assess the effectiveness of immunomodulators in the treatment of chronic obstructive pulmonary disease.